Marco Zanotto

Verona, 37134, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Gα15 in early onset of pancreatic ductal adenocarcinoma.

Gα15 in early onset of pancreatic ductal adenocarcinoma.

Journal: Scientific reports

Published: January 16, 2021

Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer.

Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer.

Journal: Molecular cancer therapeutics

Published: March 22, 2019

MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.

MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.

Journal: Anticancer research

Published: February 10, 2018

Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients.

Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 15, 2016

An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.

An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 29, 2016

Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment.

Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment.

Journal: Anti-cancer drugs

Published: October 17, 2015

TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.

TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.

Journal: British journal of cancer

Published: April 01, 2015

Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells.

Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells.

Journal: British journal of cancer

Published: December 24, 2014

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.

Journal: Oncotarget

Published: June 26, 2014

Toll-Like Receptor 9 Agonists for Cancer Therapy.

Toll-Like Receptor 9 Agonists for Cancer Therapy.

Journal: Biomedicines

Published: April 17, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026